Maxime Kempers

Papers

Total Citations

H-Index

About

Dr. Maxime Kempers is pioneering the automation of high-precision biological assays, with a central focus on developing robotic systems for zebrafish xenograft models. Their major contribution lies in addressing a critical bottleneck in translational cancer research: the manual, labor-intensive microinjection of cancer cells into fragile zebrafish larvae. By engineering automated microinjection platforms, Kempers has dramatically increased the throughput and reproducibility of these models, which are increasingly recognized for their power in predicting patient-specific responses to cancer therapeutics. This work, detailed in their most-cited papers from 2024 and 2025 (garnering 2 and 5 citations, respectively, in a rapidly evolving field), directly advances the potential of zebrafish xenografts as routine clinical diagnostic tools. Kempers’ research sits at the intersection of robotics, developmental biology, and oncology, offering a scalable solution that could accelerate personalized medicine. Their achievements highlight a commitment to transforming a laborious manual technique into a robust, automated pipeline, making them a key figure in the future of high-throughput in vivo drug screening.